Publications

2023 | Transplantation and Cellular Therapy

Comparison of vital status, cause of death, and follow-up after HCT in linked CIBMTR and California Cancer Registry data, 1991-2018.

Authors:

Valcarcel B, Meyer CL, Auletta JJ, Gadalla SM, Engels E, Spellman SR, Rizzo JD, Muffly L, Shaw BE, Morton LM

2023 | Bone Marrow Transplantation

Post-transplantation cyclophosphamide is associated with increased bacterial infections.

Authors:

Ustun C, Chen M, Kim S, Auletta JJ, Batista MV, Battiwalla M, Cerny J, Gowda L, Hill JA, Liu H, Munshi PN, Nathan S, Seftel MD, Wingard JR, Chemaly RF, Dandoy CE, Perales MA, Riches M, Papanicolaou GA

2023 | Best Practice & Research. Clinical ...

The role of randomized controlled trials, registries, observational databases in evaluating new interventions.

Authors:

Gale RP, Zhang MJ, Lazarus HM

2023 | Clinical Trials

Statistical rules for safety monitoring in clinical trials.

Authors:

Martens MJ, Logan BR

2023 | Human Immunology

Combined imputation of HLA genotype and self-identified race leads to better donor-recipient matching.

Authors:

Israeli S, Gragert L, Madbouly A, Bashyal P, Schneider J, Maiers M, Louzoun Y

2023 | Transplantation and Cellular Therapy

Severity of chronic graft-versus-host disease and late effects following allogeneic hematopoietic cell transplantation for adults with hematologic malignancy.

Authors:

Lee CJ, Wang T, Chen K, Arora M, Brazauskas R, Spellman SR, Kitko C, MacMillan ML, Pidala JA, Badaway SM, Bhatt N, Bhatt VR, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla S, Hashmi S, Hematti P, Hossain NM, Inamoto Y, Lekakis LJ, Sharma A, Solomon S, Lee SJ, Couriel DR

2023 | Blood Advances

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: A CIBMTR analysis.

Authors:

Murthy HS, Zhang MJ, Chen K, Ahmed S, Deotare U, Ganguly S, Kansagra A, Michelis FV, Nishihori T, Patnaik M, Abid MB, Aljurf M, Arai Y, Bacher U, Badar T, Badawy SM, Ballen K, Battiwalla M, Beitinjaneh A, Bejanyan N, Bhatt VR, Brown VI, Martino R, Cahn JY, Castillo P, Cerny J, Chhabra S, Copelan E, Daly A, Dholaria B, Diaz Perez MA, Freytes CO, Grunwald MR, Hashmi S, Hildebrandt GC, Jamy O, Joseph J, Kanakry CG, Khera N, Krem MM, Kuwatsuka Y, Lazarus HM, Lekakis LJ, Liu H, Modi D, Munshi PN, Mussetti A, Palmisiano N, Patel SS, Rizzieri DA, Seo S, Shah MV, Sharma A, Sohl M, Solomon SR, Ulrickson M, Ustun C, van der Poel M, Verdonck LF, Wagner JL, Wang T, Wirk B, Zeidan A, Litzow M, Kebriaei P, Hourigan CS, Weisdorf DJ, Saber W, Kharfan-Dabaja MA

2023 | Blood Advances

Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: A CIBMTR analysis.

Authors:

Taylor MR, Cole SW, Strom J, Brazauskas R, Baker KS, Phelan R, Buchbinder D, Hamilton B, Schoemans H, Shaw BE, Sharma A, Bhatt NS, Badawy SM, Winestone LE, Preussler JM, Mayo S, Jamani K, Nishihori T, Lee MA, Knight JM

2023 | Transplantation and Cellular Therapy

Incidence and impact of fungal infections in post-transplant cyclophosphamide (PTCy)-based graft-versus-host disease prophylaxis and haploidentical hematopoietic cell transplantation: A CIBMTR analysis.

Authors:

Papanicolaou GA, Chen M, He N, Martens MJ, Kim S, Batista MV, Bhatt NS, Hematti P, Hill JA, Liu H, Nathan S, Seftel MD, Sharma A, Waller EK, Wingard JR, Young JH, Dandoy CE, Perales MA, Chemaly RF, Riches M, Ustun C

2023 | Bone Marrow Transplantation

Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: Final report of BMT CTN 2002.

Authors:

Meyers G, Hamadani M, Martens M, Ali H, Chevallier P, Choe H, Harris AC, Holler E, van Hooren E, Klaassen W, Leifer E, van Oosterhout Y, Perez L, Pusic I, Stelljes M, van der Velden W, Ammatuna E, Beauvais D, Cornillon J, Maziarz RT, Schetelig J, Romeril J, MacMillan ML, Levine JE, Socie G

2023 | Transfusion

The effect of increased collect pump rate on collection efficiency in hematopoietic progenitor cell collection by apheresis in allogeneic adult donors-A single center analysis.

Authors:

Miller A, Davies J, Young K, Eckman E, Lo MY, Erskine H, Knutson L, Ondricek S, Margolis JM, Auletta JJ, Miller JP, Stefanski HE, Devine S, Pham HP

2023 | Bone Marrow Transplantation

No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma.

Authors:

Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Lund TC, Prestidge T, Rangarajan HG, Dvorak CC, Auletta JJ, Kent M, Hashem H, Talano JA, Rotz SJ, Fraint E, Myers KC, Leung W, Sharma A, Bhatt NS, Driscoll TA, Yu LC, Schultz KR, Qayed M, Broglie L, Eapen M, Yanik GA

2023 | Lifetime Data Analysis

Dynamic treatment regimes using Bayesian additive regression trees for censored outcomes.

Authors:

Li X, Logan BR, Hossain SMF, Moodie EEM

2023 | Blood

A Phase 2 Trial of CD24Fc for Prevention of Graft-vs-Host Disease

Authors:

Magenau JM, Jaglowski S, Uberti J, Farag SS, Mansour Riwes M, Pawarode A, Anand S, Ghosh M, Maciejewski J, Braun TM, Devenport M, Lu S, Banerjee B, DaSilva C, Devine SM, Zhang MJ, Burns LJ, Liu Y, Zheng P, Reddy P

2023 | Transplantation and Cellular Therapy

Impact of donor statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Authors:

Rashid N, Gooley T, Furlong T, Lee SJ, Storb R, Martin PJ, Mielcarek M

2023 | Journal of Clinical Oncology

Allogeneic hematopoietic cell transplantation improves outcome in myelodysplastic syndrome across high-risk genetic subgroups: Genetic analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study.

Authors:

Versluis J, Saber W, Tsai HK, Gibson CJ, Dillon LW, Mishra A, McGuirk J, Maziarz RT, Westervelt P, Hegde P, Mukherjee D, Martens MJ, Logan B, Horowitz M, Hourigan CS, Nakamura R, Cutler C, Lindsley RC

2023 | Communications in Statistics: Simulatio...

Adjusted curves for clustered survival and competing risks data.

Authors:

Khanal M, Kim S, Ahn KW

2023 | Transplantation and Cellular Therapy

Existence of HLA-mismatched unrelated donors closes the gap in donor availability regardless of recipient ancestry.

Authors:

Chowdhury AS, Maiers M, Spellman SR, Deshpande T, Bolon YT, Devine SM

2023 | medRxiv : The Preprint Server for Healt...

Critical illness risk and long-term outcomes following intensive care in pediatric hematopoietic cell transplant recipients.

Authors:

Zinter MS, Brazauskas R, Strom J, Chen S, Bo-Subait S, Sharma A, Beitinjaneh A, Dimitrova D, Guilcher G, Preussler J, Myers K, Bhatt NS, Ringden O, Hematti P, Hayashi RJ, Patel S, De Oliveira SN, Rotz S, Badawy SM, Nishihori T, Buchbinder D, Hamilton B, Savani B, Schoemans H, Sorror M, Winestone L, Duncan C, Phelan R, Dvorak CC

2023 | medRxiv : The Preprint Server for Healt...

Measurable residual IDH1 before allogeneic transplant for acute myeloid leukemia.

Authors:

Gui G, Dillon LW, Ravindra N, Hegde PS, Andrew G, Mukherjee D, Wong Z, Auletta JJ, Chaer FE, Chen E, Chen YB, Corner A, Devine SM, Iyer S, Jimenez-Jimenez AM, De Lima MJG, Litzow MR, Kebriaei P, Spellman SR, Zeger SL, Page KM, Hourigan CS